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  40 
ABSTRACT 41 
The neuromodulation of the greater occipital nerve (GON) has proved effective to 42 
treat chronic refractory neurovascular headaches, in particular migraine and cluster headache. 43 
Moreover, animal studies have shown convergence of cervical and trigeminal afferents on the 44 
same territories of the upper cervical and lower medullary dorsal horn (DH), the so-called 45 
trigeminocervical complex (TCC), and recent studies in rat models of migraine and 46 
craniofacial neuropathy have shown that GON block or stimulation alter nociceptive 47 
processing in TCC. The present study examines in detail the anatomy of GON and its central 48 
projections in the rat applying different tracers to the nerve and quantifying its ultrastructure, 49 
the ganglion neurons subserving GON, and their innervation territories in the spinal cord and 50 
brainstem. With considerable intersubject variability in size, GON contains on average 900 51 
myelinated and 3300 unmyelinated axons, more than 90% of which emerge from C2 ganglion 52 
neurons. Unmyelinated afferents from GON innervates exclusively laminae I-II of the lateral 53 
DH, mostly extending along segments C2-3. Myelinated fibers distribute mainly in laminae I 54 
and III-V of the lateral DH between C1 and C6 and, with different terminal patterns, in medial 55 
parts of the DH at upper cervical segments, and ventrolateral rostral cuneate, paratrigeminal, 56 
and marginal part of the spinal caudal and interpolar nuclei. Sparse projections also appear in 57 
other locations nearby. These findings will help to better understand the bases of sensory 58 
convergence on spinomedullary systems, a critical pathophysiological factor for pain referral 59 
and spread in severe painful craniofacial disorders. 60 
 61 
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ABBREVIATIONS: 3dON, third occipital nerve; AS, m. auricularis superior; AT, m. 65 
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  78 
1. INTRODUCTION 79 
The Greater Occipital Nerve (GON) is the major component of the second spinal 80 
nerve (C2). It forms the medial division of the posterior branch of C2, which emerges after this 81 
branch sends communicating branches to C1 and C3 and a few twigs to deep nuchal muscles. 82 
In humans, the GON pierces the muscles supraspinalis capitis (often) and trapezius 83 
(sometimes), as well as the deep fascia, to supply sensory innervation to a wide occipital part 84 
of the scalp (reviewed in Kemp, Tubbs & Cohen-Gadol, 2011). The anesthetic block of the 85 
GON has been used for decades to alleviate some types of primary headaches, and the interest 86 
in its anatomy has not ceased to grow in parallel to the development of more refined 87 
diagnostic and therapeutic manipulations of the GON to deal with a variety of craniofacial 88 
pain disorders (reviewed in Chen et al., 2015; Dodick et al., 2015; Inan et al., 2015; Tang, 89 
Kang, Zhang & Zhang, 2017; Young, 2010). 90 
An intriguing feature of some primary headaches is their extensive location from the 91 
face to occipital regions, a distribution that spans innervation territories of the first and second 92 
trigeminal branches and the upper cervical spinal nerves. Likewise, artificial or pathological 93 
stimulation of occipital or nuchal structures, or the infratentorial dura, often evoke referred 94 
pain in frontal regions (Goadsby & Bartsch, 2010; Piovesan et al., 2001). Among the various 95 
mechanisms proposed to explain referred cephalic pain, a convergence of afferents from 96 
different territories and submodalities on central neurons has been favored, following early 97 
reports of electrophysiological and anatomical convergence on upper cervical or medullary 98 
dorsal horn (DH) in cats (Abrahams, Anstee, Richmond & Rose, 1979; Kaube, Keay, Hoskin, 99 
Bandler & Goadsby, 1993; Kerr, 1972; Kerr & Olafson, 1961; Sessle, Hu, Amano & Zhong, 100 
1986). More recent reports in the rat examined the topographical convergence of primary 101 
afferents on the first cervical segments and caudal spinal trigeminal nucleus (Pfaller & 102 
Arvidsson, 1988; Xiong & Matsushita, 2000) and proved the existence of direct functional 103 
coupling, particularly of meningeal and cervical afferents, on DH neurons (Bartsch & 104 
Goadsby, 2002; Goadsby & Bartsch, 2010). 105 
The GON has recently become a useful target for testing how its block or stimulation 106 
in a rat model of migraine affects mechanical and nociceptive thresholds in the head and 107 
elsewhere (De La Cruz et al., 2015; Walling et al., 2017), and alters trigeminovascular 108 
nociceptive processing in the spinal trigeminal nucleus (Lyubashina, Panteleev & Sokolov, 109 
2017). However, available data on the GON anatomy and connections in the rat is scanty, 110 
being limited to two early studies using HRP transport (Neuhuber & Zenker, 1989; Scheurer, 111 
Gottschall & Groh, 1983). Therefore, we decided to examine in further qualitative and 112 
quantitative detail the fiber content of the GON, the primary sensory neurons from which they 113 
emerge, and their central axonal projections in the spinal cord and the brainstem of the rat.   114 
 115 
2. MATERIAL AND METHODS 116 
2.1.  Subjects 117 
Twenty-eight 3-month-old male Sprague-Dawley rats born from different litters from 118 
Harlan (Harlan Iberia, Barcelona, Spain) and Charles River (Charles River Laboratories, 119 
Barcelona, Spain) were used in this study. All procedures followed the regulations issued by 120 
the Ethical Committee of the Autonoma University of Madrid and the European Community’s 121 
Council Directive 2010/63/UE.  122 
2.2.  Surgery and tracer delivery to the GON 123 
Tracer deposits were made in 16 rats anesthetized by intramuscular injection of a 0.2 124 
ml/100 g of a solution containing a mixture of Ketamine (Ketolar, 55 mg/kg), Xylazine 125 
(Rompun, 15 mg/kg) and Atropine (0.2 g/kg). A midline incision was made from the 126 
interparietal suture rostral to lambda to the 3d cervical vertebra. The skin was retracted 127 
laterally and the GON and the 3d occipital nerve were identified through the thin layers of 128 
fascia and superficial muscles (Fig. 1). About 2-3 mm of the GON just before the nerve gives 129 
its first superficial twigs were isolated and exposed by carefully separating it from the 130 
surrounding muscular and connective tissue.  131 
One group of animals (Group 1, n=13) received an intraneural injection in the GON 132 
(Figs. 2, 3) of a mixture of 1% cholera toxin B (CTB, Sigma-Aldrich), 2% isolectin IB4 from 133 
Griffonia simplicifolia (IB4, Vector Laboratories) and traces of the supravital dye light green 134 
(Sigma-Aldrich), using a glass micropipette (A-M Systems, Sequim, WA; 20–30 µm tip outer 135 
diameter) coupled to a 10 μl Hamilton syringe. As previously described (Fernández-Montoya, 136 
Martin, Negredo & Avendano, 2017) a narrow pliable metal plate was carefully placed under 137 
the exposed nerve and 1-1.5 μl of the tracer mixture were injected in 3-4 pulses over 30 138 
minutes. Finally, the region was rinsed with saline and the skin was sutured with a 2/0 silk 139 
suture. 140 
In order to examine the possibility of local contamination by the tracers injected, in a 141 
second group of cases (Group 2, n=2) the GON was exposed in the same manner but left 142 
undamaged, and the same amount of CTB-IB4 was instilled and left in place for 30 min 143 
before rinsing and closing the wound. Another group of animals (Group 3, n=3) received an 144 
intraneural deposit in the GON of a 5% suspension of Fast Blue (FB, Sigma-Aldrich) in 145 
DH2O. The nerve was exposed and transected, and the proximal stump was introduced in a 146 
small glass or plastic vial containing the tracer. After 1 hour, the vial was removed, the region 147 
was rinsed and the skin sutured.  148 
2.3.  Histological processing of tracer-injected cases 149 
Animals from Groups 1 and 2 (CTB/IB4 applications) survived 4 days. They were 150 
euthanized by an intraperitoneal injection of sodium pentobarbital (Dolethal, 50 mg/kg) and 151 
perfused through the heart with 4% paraformaldehyde in 0.1M phosphate buffer (PB; pH 7.4). 152 
Ganglia C2 and C3 and the cervical spinal cord and caudal two-thirds of the brainstem were 153 
dissected out, postfixed in the same fixative overnight at 4ºC and cryoprotected with a 30% 154 
sucrose solution in 0.1M PB for 2 days. The ganglia were frozen and serially cut at 15 μm in a 155 
Leica CM1950 cryostat (Leica Biosystems, Nussloch, GmbH). Every second section was 156 
incubated overnight at 4ºC with a combination of two primary antibodies (Table 1), goat anti-157 
IB4 and rabbit anti-CTB. After several washes with saline PB (PBS), the sections were 158 
incubated for 2 h in the dark in a mixture of secondary antibodies: donkey anti-goat 159 
AlexaFluor 488 and donkey anti-rabbit AlexaFluor 647. Nuclei were labeled with 160 
Bisbenzimide. The blocks including cervical spinal cord and brainstem were frozen cut in 161 
horizontal (n=13) or coronal (n=2) sections of 40 μm in a sliding microtome (Leica SM2400, 162 
Leica Biosystems, Nussloch). In two cases of Group 1, alternate sections were processed free-163 
floating using the same immunofluorescence protocol. The remaining cases were processed 164 
free-floating using the avidin–biotin–peroxidase method (ABC), with diaminobenzidine 165 
(DAB) as a chromogen as previously described (Fernández-Montoya et al., 2017). Briefly, 166 
after endogenous peroxidase inactivation and preincubation in a blocking solution containing 167 
2% Triton X-100, alternate series were incubated with either goat anti-IB4 (1:1000; Vector 168 
Laboratories) or rabbit anti-CTB (1:500; Sigma Aldrich) overnight at 4ºC under agitation. 169 
After several washes, sections were then incubated for two hours at room temperature, with 170 
the rabbit anti-goat (1:250; Vector Laboratories) or goat anti-rabbit (1:500; Sigma Aldrich) 171 
biotinylated secondary antibodies corresponding to each series. Finally, both series were 172 
incubated in an avidin-biotin (Kit ABC Elite®, Vector laboratories) solution in PBS 0.02M 173 
with 2% Triton X-100, and revealed in 0.05% DAB in 0.1M PB with 0.008% cobalt chloride 174 
and 0.0064% nickel sulfamate, adding 0.001% H2O2. In the two animals cut on the coronal 175 
plane, a series of alternate sections were stained with 0.1% cresyl violet. All sections were 176 
mounted on subbed glass slides, dehydrated, defatted and coverslipped with DePeX. 177 
Animals from Group 2 (FB deposits in GON) survived 6 days and then were deeply 178 
anesthetized, perfused and had their C2 and C3 ganglia and a spinal cord-brainstem block 179 
extracted as in Group 1. The ganglia were cryoprotected, frozen and serially cut at 20 μm in a 180 
cryostat; the spinal cord-brainstem block was frozen cut in horizontal sections of 40 μm in a 181 
sliding microtome. After mounting and drying in the dark, sections were quickly dehydrated 182 
in ethanol, defatted in xylene and coverslipped with DePeX. 183 
2.4. Antibody characterization 184 
All antibodies used in this study are commercially available and their supplier, host 185 
species and dilutions are indicated in Table 1.  186 
The rabbit polyclonal anti-Cholera Toxin antibody consists of two subunits, A (27 187 
kDa) and B (12 kDa). This antiserum showed no binding to Staphylococcus enterotoxins A or 188 
B, or Pseudomonas exotoxin, but it bound specifically to cholera toxin, a widely used axonal 189 
tracer (manufacturer´s datasheet). In several studies, the specificity was demonstrated by the 190 
presence of immunolabeling in specific locations on the ipsilateral side of the spinal cord and 191 
lack of immunolabeling on the contralateral side (reviewed in Shehab et al., 2015). This 192 
antibody was used with Alexa Fluor 647 donkey anti-rabbit secondary antibody. 193 
The goat monoclonal Anti- Griffonia Simplicifolia Lectin I antibody has been well 194 
characterized previously. For example, it was shown that in spinal cord sections from a 195 
control rat which were did not receive IB4, this antibody did not show specific staining (Kim 196 
et al., 2008; Shehab, 2009). This antibody was used with Alexa Fluor 488 donkey anti-goat 197 
secondary antibody. 198 
The same antibodies against CTB and IB4 were used in a previous study from our 199 
laboratory (Fernández-Montoya et al., 2017), and the results were comparable to those 200 
presented here. 201 
The goat polyclonal anti-choline acetyltransferase antibody specifically recognizes a 202 
single band of 68-70 kDa on Western blots of rat peripheral nerves (Brunelli et al, 2005) and 203 
mouse brain lysates (manufacturer´s technical information). ChAT has been widely used for 204 
detecting motoneurons and their axons (Castro, Negredo & Avendaño, 2008; Kaneyama & 205 
Shirasaki, 2018).  206 
The rabbit polyclonal anti-Tyrosine Hydroxylase recognizes a single band of 62 kDa 207 
on Western blots (according to manufacturer´s datasheet). This antibody has proven useful to 208 
label sympathetic postganglionic axons and terminals (Castro et al., 2008; Gautron et al. 209 
2010).  210 
Negative controls, omitting the primary antibodies, yielded no staining in the GON. 211 
Positive controls were simultaneously done on spinal cord sections for ChAT, and cerebral 212 
cortex sections for TH, resulting in well-characterized labeling of motoneurons and 213 
intracortical axons, respectively. 214 
2.5. Methacrylate embedding of C2 and C3 dorsal root ganglia 215 
Animals in Group 4 (n=10) were deeply anesthetized and perfused with 4% 216 
paraformaldehyde-0.1% glutaraldehyde in 0.1M PB and. In eight of these rats, ganglia C2 and 217 
C3 were collected bilaterally and postfixed in fresh-buffered 4% paraformaldehyde for 2-3 218 
days. They were then dehydrated in graded ethanol solutions and infiltrated in 219 
glycolmethacrylate (Technovit 7100 Kulzer, Wehrheim, Germany) for 3 days. Both ganglia 220 
from each side and case were rolled free and embedded in one block, which was exhaustively 221 
sectioned in a rotary microtome (Microm HM 350 S, Thermo-Fisher, Walldorf, Germany) at 222 
40 μm. All sections were serially mounted on glass slides and Nissl-stained with 0.1% cresyl 223 
violet. 224 
2.6.  Treatment of GONs for electron microscopy and immunostaining 225 
In eight animals of Group 4, a 2 mm piece of the GON was excised, uni- or bilaterally, 226 
and postfixed for 2 days in a buffered 2% paraformaldehyde and 2% glutaraldehyde mixture. 227 
The nerves were osmicated (1% OsO4 in 0.1M PB), dehydrated and embedded in Durcupan 228 
resin (Fluka AG, Buchs, Switzerland). Consecutive semithin and ultrathin sections were 229 
obtained using a Leica Ultracut UCT ultramicrotome (Leica Microsystems AG, Wetzlar, 230 
Germany) and a diamond knife (Drukker International B.V., Cuijk, The Netherlands). 231 
Semithin sections (0.75-1 m) were stained with 0.5% toluidine blue (Merck). Ultrathin 232 
sections (60-70 nm) were collected on 200-mesh copper grids and stained with uranyl acetate 233 
and lead citrate.  234 
In semithin sections of three GONs randomly chosen, immunohistochemistry was 235 
performed for tyrosine hydroxylase (TH) and choline acetyltransferase (ChAT) to examine 236 
whether GON contains sympathetic or motor fibers, respectively, as reported previously 237 
(Castro et al., 2008). In short, mounted sections were etched with a mixture of sodium 238 
ethanolate and propylene oxide and de-osmicated with 2% sodium metaperiodate. Before 239 
carrying out the immunostaining endogenous peroxidase was inactivated with 1% hydrogen 240 
peroxide, and sections were incubated in citrate buffer for 10 min at 90°C for antigen 241 
retrieval. Semithin sections were incubated with polyclonal primary anti-TH (1:100) or anti-242 
ChAT (1:50) antibodies (Table 1). Secondary antibodies were biotinylated rabbit-anti-goat 243 
(1:50, Chemicon) and goat-anti-rabbit (1:50, Vector Laboratories). After washes, sections 244 
were incubated in avidin-biotin (1:250, Kit ABC Elite®, Vector Laboratories) in PBS for 2 245 
hours and reacted with diaminobenzidine (DAB, 0.05%, Sigma-Aldrich). The reaction was 246 
stopped by washing with PB 0.1 M and intensified with 0.02% buffered osmium tetroxide for 247 
2 min. After thorough washing, the sections were dehydrated, defatted and coverslipped with 248 
DePeX. Negative controls, omitting the primary antibodies, yielded no staining. Positive 249 
controls were simultaneously done on thin cryostat sections of the spinal cord and produced 250 
well characterized labeling.  251 
2.7.  Microscopy 252 
Semithin GON sections, methacrylate-embedded ganglia, DAB-reacted tissues and in 253 
general control material was examined and photographed under transmitted light microscopy 254 
in an Olympus BX61 microscope using dry (2x planapochromatic, 4x, 10x and 20x 255 
superplanapochromatic, Olympus) and oil-immersion (100x, 1.40 NA, UPlanSApo, Olympus) 256 
objectives, and a DP71 video-camera (Olympus-Europa, Hamburg, Germany).  257 
Confocal microscopy images of fluorescent material were obtained with a TCS SP5 258 
Spectral Leica confocal microscope using a 40x oil immersion objective for the ganglia; the 259 
spinal cord-brainstem sections were studied with dry 10x and oil-immersion 40x lenses. The 260 
images were acquired at 1024×1024 pixels. Image stacks and merged channel panels were 261 
obtained with the Leica LAS AF software. 262 
The ultrastructural study of the GON was carried out in a Jeol 1010 electron 263 
microscope (Tokyo, Japan) equipped with a CCD camera (Gatan BioScan, Pleasanton, CA, 264 
USA). Low power (120x) images of the nerves were obtained for reference and sampling 265 
design (see Stereology, below); higher power (8000x) images were captured to show in 266 
sufficient detail both myelinated and unmyelinated axons. 267 
Corel Photopaint and CorelDraw software (v. X3, Corel, Ottawa, Canada) was used 268 
for figure composition and digital processing, which was limited to adjustments in gray scale, 269 
brightness and/or contrast, to enhance information. 270 
2.8.  Stereology 271 
Immunofluorescent neuron numbers in DRG 272 
The total number of labeled neurons with CTB and IB4 in the C2 and C3 ganglia was 273 
estimated using the physical fractionator method (Gundersen, 1986; Howard & Reed, 1998). 274 
One in four sections was examined and photographed in the confocal microscope using 275 
separately the red and green channels and with both channels merged. A series of pairs of 0.5 276 
µm-thick pictures were taken with a 5 µm intrapair separation in the z-axis, covering 277 
completely the sampled section. Each section was systematically sampled off-line with 278 
unbiased frames overlaid on the images with the help of CorelDraw software. Somatic 279 
profiles of immunofluorescent neuronal perikarya were used as counting units. The labeled 280 
profiles fulfilling the counting criteria were quantified in both directions of the disector 281 
separately for CTB- and IB4-labeled, and cells co-localizing both tracers. Final sampling 282 
fraction (FT) was 1:24, and 120 neurons were counted on average (Q-) on about 70 disector 283 
fields in C2 and C3 per side. Total estimates were computed as  ?̂? =  Σ𝑄− ∙ 𝐹𝑇
−1 . A similar 284 
procedure was performed for cases receiving the tracer FB. 285 
The precision of the individual estimates was approximated by estimating the error 286 
variance due to the stereological procedure, which is represented by the coefficient of error 287 
(CE), as previously reported (Avendaño, Machin, Bermejo & Lagares, 2005; Cruz-Orive, 288 
2004). The mean CEs of the estimates for the total number of labeled neurons ranged between 289 
8.9–10.4%. As expected, estimates of much sparser subpopulations (e.g., double labeled 290 
neurons, or labeled neurons in C3, if counted separately from those in C2) resulted in higher 291 
CEs. 292 
Number and somatic volume of neurons in C2 and C3 ganglia 293 
The total number of neurons in C2 and C3 was estimated using the optical fractionator 294 
(West, Slomianka & Gundersen, 1991) on the methacrylate embedded ganglia. In all 295 
appropriately sampled neurons the somatic volume was estimated with the planar rotator 296 
(Tandrup, Gundersen & Jensen, 1997). All stereological analyses were carried out in an 297 
Olympus BX51 microscope equipped with a high-precision motorized microscope stage 298 
(Prior Proscan II, Prior Scientific Inc., Rockland, MA), an internal 0.3 m-resolution 299 
microcator, and an Olympus DP71 digital camera. The control of the stage movements and 300 
the interactive test grids were provided by the NewCast stereological software (ver. 4.6.1.630, 301 
Visiopharm, Hørsholm, Denmark) running in a Dell Precision 390 computer.  302 
Average final sampling fraction was either 1:70 or 1:140 –both strategies yielding 303 
essentially the same results. Number estimation was computed as for the physical fractionator 304 
(see above). Section thickness measurements, cell typing and perikaryal volume estimations 305 
were performed with an oil-immersion 100x lens (1.40 NA, UPlanSApo, Olympus) at a 306 
3900x final magnification on screen. Neuron types were identified according to well 307 
established morphological criteria ( Lawson, 2005; Lieberman, 1976;  Rambourg, Clermont & 308 
Beaudet, 1983). The few (less than 5%) cells that could not be clearly identified as A- or B-309 
type were split in half and each half was ascribed to either A3 or B1 subtypes. The average 310 
precision of the stereological procedure among individual cases was 10.9% (range 7.3-311 
14.2%). 312 
Volume of CTB- and IB4-innervated territories 313 
The volume occupied by labeled axons and their varicosities was estimated by point 314 
counting, applying the Cavalieri principle (Gundersen et al., 1988) on 40 m-thick IB4- or 315 
CTB-immunolabeled sections at fixed intervals (d = 160 m), as previously reported 316 
(Fernández-Montoya et al., 2017). With the integrated stereological equipment described in 317 
the previous section, and using a planopochromatic 20x dry objective (0.75 NA, Olympus 318 
UPLSAPO), two quadratic lattices of points of different density were superimposed on the 319 
immunolabeled regions. Dorsal horn laminae III-IV, displaying the densest and most 320 
extensive innervation, was sampled with low intensity (a(p) = 4127 m2); for the remaining 321 
territories a denser grid (a(p) = 1337 m2) was used. All points displaying at least one axonal 322 
swelling within a radius of 4 μm, at any depth of the section, were included in the count. 323 
Labeling with IB4 turned out to be more diffuse, characterized by thinner axons and 324 
varicosities of small size, and its delineation was less precise in peripheral areas and areas 325 
with little labeling. To help identifying the innervated structures, separate cases with Nissl- 326 
and cytochrome oxidase-stained horizontal sections were prepared. 327 
Volume estimates were obtained as  ?̂? =  Σ𝑃 ∙ 𝑎(𝑝) ∙ ?̅?  for a number of pre-defined 328 
territories: Lamina I, lamina II, laminae III-IV (lateral parts), and deep laminae in the DH of 329 
the spinal cord and caudal medulla; patches in the medial parts of the spinal DH; projections 330 
in and rostral to the dorsal column nuclei (DCN); and the interpolar nucleus of the trigeminal 331 
complex (Sp5i). Sparse projections in other regions were not measured. Values were not 332 
corrected for shrinkage. Average precision in the measuring procedure varied much, 333 
depending on the size of the target region: The CEs obtained ranged between 6-7% for 334 
laminae III-IV or all territories combined, to 29% for the deep DH laminae, with the weakest 335 
innervation. 336 
Morphometry of the GONs 337 
Measurements were performed at basically the same level of the GON in all cases 338 
(Fig. 2). The myelinated (MAx) and unmyelinated axons (UAx), as well as the interstitium of 339 
the GON were morphometrically assessed on ultrastructural images captured at 8000x and 340 
handled off-line with CorelDraw X3 software. A 2D fractionator design was used for 341 
estimating axon numbers, and the 2D-nucleator was applied on sampled profiles for 342 
estimating cross-sectional areas of axons and myelin sheaths (Larsen, 1998). From the areal 343 
measurements of MAx, the axonal and fiber diameters were derived to compute the g-ratio 344 
(the ratio of the inner axonal diameter to the total fiber diameter), widely held as a reliable 345 
indicator of myelination (Chomiak & Hu, 2009). The predicted CE for number estimation in 346 
each case was estimated as in Larsen (1998; Eq. A2). The mean CE was 6.3% for MAx and 347 
3.9% for UAx. Areal fractions of the GON occupied by MAx, myelin, UAx and interstitium 348 
(including endo- and perineurium, Schwann cell nuclei and cytoplasm, and other cells; 349 
excluding epineurium and large blood vessels) were estimated by point counting. 350 
2.9.  Statistics  351 
Descriptive statistics (means and SEM or SD) were obtained from the Excel program 352 
(Microsoft Office Professional Plus 2010 for Windows 10). Statistical comparisons between 353 
sides were made for neuronal numbers and perikaryal volumes of methacrylate-embedded 354 
ganglia with the help of the SPSS program (v. 15.0 for Windows). For this purpose, the 355 
Wilcoxon signed rank test for two correlated groups was applied. Statistical significance was 356 
set at a P-value < 0.05.  357 
 358 
3. RESULTS 359 
3.1.  Macroscopic anatomy of the GON 360 
As its homonymous nerve in humans and other mammalian species, the GON in the 361 
rat is the main component of the posterior branch of the second cervical spinal nerve. The 362 
earliest and nearly the only anatomical description of this nerve was provided by Scheurer et 363 
al. (1983), and present findings are consistent with that description. The posterior branch of 364 
the spinal nerve C2 is joined by communicating branches with C3 and, often, C1, and then 365 
divides into a thinner lateral branch, and a larger medial branch, which makes the GON. This 366 
nerve penetrates first the muscle semispinalis capitis, and then the clavotrapezius and/or the 367 
splenius capitis before piercing the superficial fascia and the anterior belly of the levator auris 368 
longus (LAL, Fig. 1). Along its course, the nerve gives off a variable number of small 369 
branches that apparently penetrate local muscles. In its most superficial course, the GON 370 
curves rostrolaterally and divides into a variable number of branches that distribute on the 371 
occipital region and near the medial base of the pinna. Along this course it is possible that the 372 
GON or some of its branches also pierce thin muscles that are not readily seen during surgery, 373 
such as the abductor auricularis longus or the interscutularis (Murray, Gillingwater & Parson, 374 
2010). After piercing the LAL, and before turning rostralwards and dividing into terminal 375 
branches, the GON is easily accessible for at least 2 mm, and this was the locus chosen to 376 
carry out the tracer injections or deposits and the ultrastructural study of the nerve (Fig. 2). 377 
3.2.  Tracer delivery to the GON and neuronal labeling in sensory ganglia 378 
The success of the intraneural injections of CTB-IB4 was ascertained by several lines 379 
of evidence, which pointed to a consistent and substantial uptake of the tracers by GON 380 
axons: 1, all cases showed topographically similar patterns of distribution of primary afferents 381 
in the spinal cord and brainstem. 2, the number of ganglion cell bodies that were 382 
immunofluorescent for CTB, IB4 or both tracers did not differ much across cases (coefficient 383 
of variation below 10%; Figs. 4, 5). 3, however, those numbers were significantly lower than 384 
the number of FB-labeled neurons in ganglia C2 and C3 after exposing the proximal stump of 385 
the transected GON to the tracer (Fig. 6), for reasons that will be explained in the Discussion. 386 
And 4, axon counts in the GON backed these results, as will also be discussed below. 387 
Labeled neurons were much more abundant in C2 (2016±209, CTB+IB4; 2453±133, 388 
FB) than in C3 (184±52, CTB+IB4; 256±32, FB). About 20% of neurons in C2, and 6% in C3 389 
co-expressed CTB and IB4. As expected, CTB labeled predominantly large or medium-sized 390 
neurons, while IB4 mainly appeared in small and some medium-sized neurons. However, 391 
there were occasional instances of large IB4-labeled neurons, and, more frequently, small 392 
CTB-labeled neurons. Most double-labeled neurons were small or medium-sized (Fig. 5).  393 
3.3.  Central distribution of primary afferents from the GON 394 
IB4-labeled afferents: restricted regional and laminar distribution in the spinal cord 395 
Both in tissue reacted with DAB, and in immunofluorescent material, IB4-labeled 396 
axons enter the spinal cord through the dorsal roots of C2 (very few were found in C3). In the 397 
posterolateral (Lissauer’s) tract the axons divide into short ascending and longer descending 398 
fibers that give collateral or terminal branches that enter the lateral part of the DH from the 399 
rostralmost levels of spinal segment C4 to the caudalmost levels of segment C1. No IB4-400 
labeling appears elsewhere in the spinal cord or the caudal brainstem. The innervated territory 401 
is consistently expressed as a dense band of labeling restricted to the outer two-thirds of 402 
lamina II, with more scattered immunostaining in lamina I (Fig. 7). Labeling remains in 403 
lateral parts of the DH, and mainly consists of thin axons and small varicosities. 404 
CTB-labeled afferents: widespread innervation in the spinal cord and caudal brainstem 405 
Numerous CTB-immunolabeled axons enter through all rootlets of C2 and, to a lesser 406 
extent, C3, and divide in T in a relatively wide medio-lateral stretch of the spinal cord above 407 
the DH, from Lissauer’s tract to the lateral part of the dorsal column (DC). Fibers ascending 408 
and descending in the tract give collaterals into the DH all along their course, more 409 
prominently at segmental levels C2 and C3, but which nevertheless extend abundantly and 410 
uninterruptedly between spinal segments C4 and C1. This lateral component of CTB-labeled 411 
afferents generates a dense meshwork of preterminal and terminal axons and varicosities of 412 
different sizes, with a predominance of small and medium-sized ones, in laminae III and IV of 413 
the spinal DH. Also, a narrow band of immunoreactivity labels lamina I that extends further 414 
caudally to segment C6, and sparse fibers and varicosities appear scattered in laminae V and 415 
VI (Fig. 8). At segmental levels of the DH where CTB- and IB4-immunolabeling coexist, the 416 
inner one-half of lamina II displays a mixture of axons and terminals expressing either of the 417 
two tracers, and others expressing both (Fig. 7). 418 
CTB-labeled fibers coursing caudalwards in the lateral parts of the DC from C2 soon 419 
penetrate the DH to end as a few small terminal patches in laminae III-IV. No similar 420 
afferents are seen originating from C3 dorsal roots. In contrast, rostrally directed axons in the 421 
DC are more abundant and distribute in a variety of terminal territories (Figs. 8, 9). These 422 
axons can be followed from their origin in the division of primary afferents, advancing near 423 
the medial surface of the upper cervical and caudal medullary DH with a slight dorsal shift 424 
until reaching the lateral surface of the cuneate nucleus. They then proceed into the wedge-425 
shaped space that exists between the rostral and external cuneate nuclei and the medial edge 426 
of the trigeminal tract, where nucleus x, the dorsolateral reticular nucleus, and the ventral part 427 
of the inferior (spinal) vestibular nucleus have been defined previously (Bermejo, Jiménez, 428 
Torres & Avendaño, 2003; Paxinos & Watson, 1986), and vanish in this region about 1.5 mm 429 
rostral to the obex. Along their whole course adjacent to the DH small bundles of axons 430 
descend and terminate at regular intervals in 10-12 restricted patches that apparently end in 431 
the most medial part of lamina III. None of them seemingly invades the internal basilar 432 
nucleus. At the level of the most rostral of these patches, about 1 mm caudal to the obex, a 433 
few scattered varicose fibers descend further towards the central canal, and some cross the 434 
midline dorsal to the canal within the commissural division of the nucleus of the solitary tract 435 
to end soon at the base of the contralateral DH. Other scattered fibers appear in deeper 436 
laminae (deep IV and V) from the caudal part of Sp5c through spinal segment C3 probably 437 
reaching, very sparsely, the central cervical nucleus and the dorsomedial part of the ventral 438 
horn. It could not be decided which of these deep afferents derive from the fibers coursing 439 
medially or laterally along the DH. 440 
The fiber bundle that advances rostrally abutting the DCN is relatively compact and 441 
rich in varicosities. These could innervate adjoining parts of the medial, rostral or external 442 
divisions of the cuneate nucleus complex (Bermejo et al., 2003), but without sending obvious 443 
offshoots into these nuclei. Near the rostral end of this bundle, a moderate number of fibers 444 
turn laterally into the dorsal part of the trigeminal tract above the trigeminal nucleus Sp5i. 445 
Some remain there distributing within the paratrigeminal nucleus (Pa5), but others collect into 446 
a few small bundles that descend dropwise along the innermost surface of the trigeminal tract. 447 
Fibers originating from these bundles enter the trigeminal nuclei to form patches of terminal 448 
fields irregularly distributed along the dorsoventral extent of Sp5c and the caudal one-half of 449 
Sp5i (Figs. 8, 9). No labeled fibers appear further rostrally, into the oral or principal divisions 450 
of the trigeminal nuclei. 451 
Quantitative data on the central innervation of GON fibers 452 
On a superficial observation, it was noticed that thin axons and small varicosities were 453 
dominant in lamina II and in the lateral portions of laminae III-IV in the DH and in Sp5i, 454 
while they were less prominent among relatively more abundant thicker axons and larger 455 
varicosities in the DCN, in the medial patches and at deeper levels of the DH, and in lamina I. 456 
Also, both terminal and en passant varicosities were found in all territories (Fig. 10).  457 
Although no attempt was made to quantitate the different types of labeled axons and 458 
varicosities in this study, the overall volume of the innervated territories was estimated by 459 
stereological means. It was found that the volume of IB4-labeled tissue, nearly all of it in 460 
lamina II, covered 0.203±0.012 mm3, which represents more than one-half of the overall 461 
volume of the territories innervated by CTB-labeled fibers (0.393±0.036 mm3). And within 462 
the latter, more than three-quarters (0.303±0.022 mm3) corresponded to laminae III-IV in the 463 
DH (Fig. 11). 464 
Retrograde labeling 465 
In all cases, motoneurons appeared retrogradely labeled by CTB or FB (but not IB4) in 466 
the medial division of the facial nucleus and in the ventral horn of spinal segments C1-C3. 467 
Their cell bodies and dendrites were strongly labeled, and their axons were readily followed 468 
along the central course of the facial nerve and the ventral roots. None or very few of the 469 
labeled primary afferents were traced to the vicinity of these neurons, and their axons were 470 
smooth and gave no collaterals that could be mistaken for primary afferents. This 471 
motoneuronal labeling also occurred in the sham-injected animals and was due presumably to 472 
contamination of local muscles or nerve twigs, not to the presence of skeletomotor fibers in 473 
the GON (see Discussion). 474 
3.4.  The primary sensory neurons in C2 and C3 475 
All morphological types of sensory neurons described in DRG of various mammalian 476 
species were identified in the present material. A-type neurons are large, and contain small or 477 
medium-sized clumps of Nissl substance, homogeneously distributed across the cytoplasm, or 478 
more abundant in the central portions of the cytoplasm and sparser at the periphery. Their 479 
nucleus is large and lightly stained, with a prominent and heavily stained nucleolus centrally 480 
located. The B-type neurons are smaller and rather heterogeneous in shape and Nissl-based 481 
cytological features. In general, they contain coarser clumps of Nissl substance that are 482 
scantier or even missing altogether, in perinuclear regions of the cytoplasm. The aggregation 483 
of Nissl clumps can adopt various forms, from a single peripheral rim to a relatively uniform 484 
cytoplasmic distribution. In a small fraction of B-cells, the nuclei display more than one 485 
nucleolus, and smaller intranuclear accessory bodies are frequently observed. C-type neurons 486 
are very small, display little amount of Nissl substance sometimes forming local aggregates, 487 
and often have more than one relatively indistinct nucleolus. 488 
Applying these criteria, A-cells only represented about 15% of all neurons in C2 and 489 
C3, B-cells stood out at 52%, and C-cells made up 33%. Although C3 contained about 16% 490 
fewer neurons (mostly involving small cells) than C2 this difference did not reach statistical 491 
significance, nor were there significant differences in neuron numbers between the right and 492 
left ganglia (Table 2). Significant lateral differences, however, were detected in the somatic 493 
volume of large neurons. A-cells were on average 16% larger in the right compared to the left 494 
ganglia, a difference that increased to 22% when only C2 was considered. Lateral differences 495 
were not found for other cell types, nor for all neurons pooled (Fig. 12). 496 
3.5.  Light- and electron-microscopy of the GON 497 
At the level of the superficial fascia, the GON exhibits an apparent width around 0.5-498 
1.0 mm. A large fraction of the nerve, however, consists of a thick and loose epineurium, 499 
which hides a notably thinner nerve trunk, often divided into up to 4 separate fascicles, each 500 
surrounded by a thin but dense layer of perineurium (Fig. 13). The absolute values obtained 501 
from cross-sectional areal measurements of the GON are of little informative value, since its 502 
fascicles, and fiber groups therein, often follow a somewhat winding course inside the 503 
epineurium. In relative terms, however, it was found that myelinated fibers occupied a fairly 504 
stable 61% of the nerve, while the interstitium (including as such the endo- and perineurium, 505 
plus Schwann cell nuclei and cytoplasm excluding myelin, and other cell types) took a sizable 506 
34% (Table 3). 507 
Stereological estimates of axon numbers (Table 3) showed a notable variability among 508 
the 11 GONs (5 on the left, 6 on the right) examined, with coefficients of variation ranging 509 
between 18% for MAx on the right to 53% for MAx on the left, and around 30% for UAx on 510 
either side. On average, MAx represented only 21% of all axons in the nerve. In several cases, 511 
an additional 1-2% of myelinated profiles apparently corresponded to degenerating MAx. Up 512 
to 20 UAx appeared in some cases ensheathed by a single non-myelinating Schwann cell; 513 
more commonly, these Remak bundles contained 8-10 UAx, while glial profiles ensheathing 514 
1-2 UAx were rarely found. The degree of myelination of MAx assessed by the g-ratio was 515 
essentially identical on both sides, and correlated significantly with the size of MAx, the 516 
thickest fibers exhibiting values twice as high as the thinnest (Fig. 14). Not a single MAx 517 
displayed ChAT-immunolabeling, indicating that the GON does not have motor fibers at least 518 
along its subcutaneous course. In contrast, about 20% UAx expressed TH-immunolabeling; 519 
although not formally quantified this value represents a guesstimate based on the examination 520 
of randomly sampled spots in adjacent ultrathin sections and immunoreacted semithin 521 
sections of two GONs (Fig. 15).  522 
 523 
4. DISCUSSION 524 
The main goal of this study was to provide a comprehensive anatomical assessment of 525 
the GON in the rat. The motivation for choosing this particular nerve was twofold: First, the 526 
sensory innervation of the occipital region and posterior aspect of the neck was for a long time 527 
an active area of research to understand the role of its extero- and proprioceptive contribution 528 
to postural control and coordination of eye movements. Not surprisingly, the organization of 529 
central projections from upper cervical spinal nerves was profusely investigated with every 530 
anatomical or functional method that came to life along the last century (Bolton & Ray, 2000; 531 
Escolar, 1948; Kerr, 1972; Kerr & Olafson, 1961; Neuhuber & Zenker, 1989; Pfaller & 532 
Arvidsson, 1988; Yee & Corbin, 1939) . Yet, only in two studies, using transganglionic 533 
transport of HRP, were the GON and/or its central projections specifically examined 534 
(Neuhuber & Zenker, 1989; Scheurer et al., 1983). And second, as the interest in the upper 535 
cervical afferents in that context seemed to wane, the GON got renewed attention after 536 
evidence accumulated on its involvement in the pathophysiology of referred pain in some 537 
chronic headache disorders (Magis & Schoenen, 2012; Rodrigo, Acin & Bermejo, 2017; Tang 538 
et al., 2017). Clinical findings were supported by the demonstration in different species of 539 
overlapping projections of trigeminal and cervical afferents in the upper cervical and caudal 540 
spinal trigeminal nucleus (Bartsch & Goadsby, 2002; Goadsby & Bartsch, 2010; Pfaller & 541 
Arvidsson, 1988; Xiong & Matsushita, 2000). However, given the paucity of new anatomical 542 
information on the GON in the rat, the time seemed ripe for a reappraisal of its structure and 543 
connections using more sensitive and precise tracing and quantitative studies. The present 544 
study provides a new and detailed qualitative and quantitative description of ganglia C2 and 545 
C3, as well as of the ultrastructure of the GON and its central projection pattern and 546 
innervation territories in the spinal cord and brainstem. The use of two neuron-specific 547 
tracers, CTB and IB4, has also made it possible to define subpopulations of the primary 548 
sensory neurons that subserve the GON, and recognize regional and laminar particularities in 549 
the central projections of putative myelinated and unmyelinated primary afferents coursing 550 
through the GON. 551 
4.1.  Comments on the tracing and labeling methods 552 
The cervical ganglia contributing to GON 553 
It was consistently found that ganglion C3 displayed only a small fraction of labeled 554 
neurons after any type of tracer delivery to GON. Lacking a direct proof, it may be suggested 555 
that those neurons sent their axons (or axon collaterals) to GON through the communicating 556 
branch between the dorsal branches of the spinal nerves C2 and C3 (Fig. 2). In two cases 557 
ganglion C4 was extracted but showed no labeled neurons. Ganglion C1 was not identified 558 
during surgery, however, in two cases the thin dorsal root of the first cervical nerve was 559 
examined histologically. Since no ganglion neurons were found, no further attempt was made 560 
to dissect C1. Ganglion C1 is often absent in humans (reviewed in Campos et al, 2012), and 561 
rats (Neuhuber & Zenker, 1989), although in this species it may be represented by a group of 562 
scattered neurons in only a small percentage of cases (Pfaller & Arvidsson, 1988). 563 
Spurious labeling following delivery of tracers to GON 564 
In all cases that received intraneural injections of CTB labeled motoneurons were 565 
found in the facial nucleus and the spinal ventral horn at C1-C3 levels. Such labeling also 566 
occurred when, in the first cases injected, the area of injection was thoroughly rinsed with 567 
saline, and the nerve was carefully wrapped in Parafilm® to prevent leakage of the tracer. 568 
Moreover, similar retrograde labeling resulted when the GON was exposed in the same 569 
manner but left undamaged, and the same amount of tracer was instilled and left in place for 570 
the same time as during actual injections before rinsing and closing the wound. Since ChAT 571 
immunostaining failed to label myelinated axons in the GON, it could be ruled out that the 572 
GON contained motoneuron axons. It seemed, therefore, that some tracer was taken up by 573 
local muscles or muscle nerve twigs that resulted damaged during surgery. The topographical 574 
distribution of labeled motoneurons was consistent: in the facial nucleus they remained 575 
confined within its medial division, which innervates dorsal and posterodorsal superficial 576 
auricular muscles (Friauf & Herbert, 1985; Watson, Sakai & Armstrong, 1982); in the ventral 577 
horn they were restricted to medial and central parts of this horn at caudal medullary and 578 
upper cervical levels, presumably corresponding to motoneurons of the spinal accessory 579 
nucleus innervating the clavotrapezius and sternocleidomastoid muscles (Kitamura & Sakai, 580 
1982; Ullah, Mansor, Ismail, Kapitonova & Sirajudeen, 2007). 581 
On the completeness of GON fiber labeling 582 
The procedure used here to inject a CTB-IB4 mixture into a sensory nerve was 583 
successfully tried before (Fernández-Montoya et al., 2017). However, in that study the target 584 
nerve was smaller and consisted of a single fascicle, whereas the GON often appeared divided 585 
into two or more fascicles (Fig. 12), which could raise a concern regarding the barrier 586 
imposed by the perineurium, if intact, to tracer uptake. Although the trauma caused by the 587 
injection is likely to induce a transitory general increase in perineurial permeability (Mizisin 588 
& Weerasuriya, 2011), this issue was directly addressed by two procedures: First, by applying 589 
FB to the transected GON, a method that is supposed to label all motoneurons and primary 590 
sensory neurons that send their fibers through the target nerve ( Negredo, Castro, Lago, 591 
Navarro & Avendaño, 2004; Puigdellívol-Sánchez, Prats-Galino, Ruano-Gil & Molander, 592 
2000). This procedure yielded 18% more labeled neurons in C2 and C3, suggesting that the 593 
tracers CTB and IB4 administered by intraneural injection had access to most, but not all 594 
fibers in the nerve. An additional factor that may play a role in this mismatch is that a small 595 
subpopulation of peptidergic neurons fail to take up CTB or IB4 (Shehab and Hughes 2011). 596 
The second method relied on counting the number of MAx in the GON, to assess whether it 597 
matched the number of neurons labeled by CTB in the ganglia. Although axon numbers in the 598 
GON varied greatly, and they were obtained from cases that lacked tracer injections, it was 599 
comforting that about 1000 MAx were found on average in the right GON, a value slightly 600 
below the number of neurons labeled by CTB in the ganglia, suggesting a successful uptake of 601 
the tracers by all MAx. 602 
It is more difficult to explain the notable mismatch between the number of UAx in the 603 
GON (about 3700 on the right side) and the number of IB4-labeled neurons in the (right) C2 604 
and C3 ganglia (about 1300). Although, as mentioned above, it is not possible to rule out that 605 
some axons were not sufficiently exposed to the injected IB4, and that a subpopulation of 606 
axons in the GON may not be able to take up the tracers, other explanations should be 607 
considered. For example, it was proposed that central or peripheral axons originating from 608 
ganglion cells bifurcate near the ganglion (Chung & Coggeshall, 1984; Langford & 609 
Coggeshall, 1981). More recent studies disproved this suggestion for the spinal dorsal roots 610 
(Tandrup, 1995) and the trigeminal root (L. Vazquez and C. Avendaño, Master Thesis, 2017, 611 
unpublished).  It remains possible, however, that such bifurcations may take place in 612 
peripheral nerves farther away from the ganglion, at least for UAx. A second source of the 613 
high number of UAx is the population of visceromotor autonomic axons that is known to exist 614 
in peripheral nerves, and which after being removed by an extensive sympathectomy was 615 
estimated to account for 1/3 of all UAx in the sciatic nerve and its main branches 616 
(Schmalbruch, 1986). The proportion of putative autonomic axons found in the sciatic nerve 617 
was only 19% using the approach of counting TH-immunoreactive profiles on semithin axons 618 
(Castro et al., 2008). Although not quantified, the same procedure applied to the GON in the 619 
present study revealed frequent TH-immunoreactive profiles coincident with UAx profiles. 620 
These findings suggest that the numerical mismatch between the UAx in the GON and IB4-621 
labeled ganglion neurons could be partly explained by the presence of autonomic motor axons 622 
in the nerve, and partly by an incomplete uptake of the tracer by UAx following intraneural 623 
tracer injection.  624 
4.2.  The central projections of GON as part of the spinal ganglia afferents 625 
 Our results show that GON afferents, including IB4- and CTB-labeled fibers, 626 
distribute in central territories similar to, but more extensive than those described in previous 627 
studies using more ‘classical’ techniques (reviewed in Neuhuber & Zenker, 1989; see also 628 
Scheurer et al., 1983). These territories coincide to a large extent with many of the structures 629 
innervated by fibers labeled by HRP, WGA-HRP or biotinylated dextran injected directly into 630 
spinal ganglia C2 and C3 (Neuhuber & Zenker, 1989; Pfaller & Arvidsson, 1988;  Zhan, 631 
Pongstaporn & Ryugo, 2006), except for a lack of GON projections to vestibular, cochlear, 632 
perihypoglossal, Sp5c, the central cervical, and Clarke’s dorsal nuclei in thoracic segments, 633 
which were however innervated to various degrees following C2 and/or C3 injections. It was 634 
unsettled in previous reports whether the GON projected to the external cuneate nucleus, and 635 
whether GON afferents in the spinal DH remained within the first four cervical segments, or 636 
extended as far caudal as segments T3-T4. Our findings showed no more than a few terminal 637 
fibers in the caudoventral region of the external cuneate, and failed to identify labeled fibers 638 
in the spinal cord caudal to segment C6. 639 
4.3. The trigeminocervical complex (TCC) and the central projections of the GON  640 
Primary afferents from neurons in the trigeminal ganglion project extensively to nuclei 641 
outside the central targets of GON afferents, but trigeminal and GON projection domains are 642 
not entirely segregated. Some of the trigeminal afferent territories in the spinal and medullary 643 
DH (Abrahams et al., 1979; Kerr, 1972; Kerr & Olafson, 1961; Marfurt & Rajchert, 1991; 644 
Sessle et al., 1986) match well with upper cervical terminal fields. This topographical 645 
convergence of exteroceptive, proprioceptive and visceroceptive afferents that originate from 646 
diverse head and neck regions prompted to examine the involvement of this region in 647 
craniocervical pain disorders whose pathophysiology had escaped explanation for a long time. 648 
The term ‘trigeminocervical complex’ (TCC, Hoskin, Zagami & Goadsby, 1999) was coined 649 
to encompass the caudal Sp5c and the upper 2 cervical spinal segments, particularly their 650 
laminae I-II, and the commissural division of the nucleus of the solitary tract and its caudal 651 
extension into spinal lamina X, where the electrical stimulation of the middle meningeal 652 
artery or the superior sagittal sinus induced up-regulation of c-Fos expression in cats and 653 
monkeys (Goadsby & Hoskin, 1997; Kaube et al., 1993). Supratentorial dural stimuli in the 654 
clinical setting are often accompanied by pain referred to the ophthalmic trigeminal territory 655 
in the face, which could be explained by the proximity, although not identity, of sensory 656 
neurons in the trigeminal ganglion that innervate the forehead and supratentorial dura 657 
(O'Connor & Van der Kooy, 1986). However, putatively painful stimuli in the infratentorial 658 
cranial fossa, upper cervical canal, or occipital or upper dorsal cervical structures may also 659 
elicit referred pain in the forehead (reviewed in Bartsch & Goadsby, 2002; Bogduk, 2001), 660 
suggesting that the TCC receives not only dural and neurovascular afferents from trigeminal-661 
innervated supratentorial region, but also those originating from upper cervical sensory 662 
domains including vertebrae, joints, muscles, and internal carotid and vertebrobasilar arteries.   663 
When our findings are compared with reports of trigeminal projections in the caudal 664 
brainstem and cervical spinal cord, several conclusions emerge:   665 
1, Overall, most GON projection territories also had variable amounts of trigeminal 666 
afferents, except for the lateral DH, whose laminae I-III were heavily innervated by the GON 667 
between segments C1 and C6, but were essentially free from trigeminal afferents below C2 668 
(Jacquin, Semba, Egger & Rhoades, 1983;  Marfurt & Rajchert, 1991; Pfaller & Arvidsson, 669 
1988).  670 
2, Trigeminal afferents to the lateral part of C1 and or C2, where a heavy GON 671 
projection distributes, originate from some, but not all, components of the ophthalmic 672 
division. By transganglionic tracing, afferents have been shown mainly in laminae III-IV from 673 
the frontal, supraorbital and anterior ethmoidal nerve (Panneton, Gan & Juric, 2006; 674 
Panneton, Hsu & Gan, 2010; Shigenaga et al., 1986; Takemura, Sugimoto & Shigenaga, 675 
1991), and c-Fos expression was induced in laminae I-II at the same spot by painful thermal 676 
stimuli applied to the supraorbital region (Strassman & Vos, 1993). Afferents from the middle 677 
meningeal artery also had terminals in laminae I-IV in a similar region of the DH (Liu, 678 
Broman & Edvinsson, 2008). In addition, conjunctival, but not corneal, afferents distributed 679 
in a slightly more medial position in laminae I-III of segment C1 (Panneton et al., 2010).  680 
3, Afferents from the maxillary territory, including the whiskerpad, reached the rostral 681 
portions of C1, but their location in the DH was at an intermediate position (Fernández-682 
Montoya et al., 2017; Panneton et al., 2010; Shigenaga et al., 1986; Strassman & Vos, 1993), 683 
dorsal and lateral to the main focus of CTB- and IB4-labeled terminals from the GON.  684 
4, The discontinuous patches of GON afferents in the medial DH are coincident with 685 
the central projections reported for the inferior alveolar and mylohyoid branches of the 686 
mandibular nerve (Jacquin et al., 1983; Strassman & Vos, 1993). The auriculotemporal nerve, 687 
another branch of the mandibular nerve whose cutaneous distribution is placed laterally and 688 
rostrally to that of the GON, innervates in C1 a patch (Jacquin et al., 1983) that lies 689 
immediately lateral to the GON patches. 690 
4.4. GON projections outside the TCC: overlap with other trigeminal and craniocervical 691 
afferents. 692 
GON afferents consistently distribute in three regions outside the TCC, which also 693 
receive afferents from the trigeminal, intermediate, vagus and/or upper cervical nerves other 694 
than GON. First, the ventrolateral zone of the rostral cuneate nucleus, which receives dense 695 
CTB-labeled afferents from GON, also receives trigeminal innervation from the mandibular 696 
nerve (Jacquin et al., 1983). This region is also known to receive neck muscle and cutaneous 697 
afferents (Abrahams et al., 1979;  Bolton & Tracey, 1992; Edney & Porter, 1986), which 698 
likely arise from neurons in upper cervical ganglia (Imamura, Saunders & Keller, 1986; 699 
Pfaller & Arvidsson, 1988), as well as fibers from periauricular structures innervated by the 700 
intermediate nerve (Arvidsson & Thomander, 1984), the auricular branch of the vagus nerve 701 
in cats (Nomura & Mizuno, 1984), and extraocular muscles in monkeys (Porter, 1986). 702 
Second, a moderate amount of CTB-labeled fibers from GON innervates a slender marginal 703 
band at the lateral surface of Sp5i, where trigeminal fibers end respecting a somatotopy 704 
whereby caudal parts of the face are represented more laterally (Jacquin, Stennett, Renehan & 705 
Rhoades, 1988; Jacquin et al., 1986), and where most of the nociceptive afferents in Sp5i 706 
preferentially distribute (Hayashi, Sumino & Sessle, 1984). Moreover, afferents from the 707 
palpebral and bulbar conjunctiva, but not the cornea, are known to terminate ventrolaterally in 708 
Sp5i in rabbits (Van Ham & Yeo, 1996) and rats (Panneton et al., 2010). It is noteworthy that  709 
extraocular muscle afferents (Buisseret-Delmas & Buisseret, 1990; Porter & Donaldson, 710 
1991) and afferents from the territory of innervation of  the auricular branch of the vagus 711 
nerve (Arvidsson & Thomander, 1984; Ichiyama et al., 1997; Nomura & Mizuno, 1984), 712 
similar to those projecting to the rostral cuneate, also innervate the marginal part of Sp5i. 713 
The third structure outside TCC where GON and trigeminal afferents converge is Pa5. 714 
This is the major interstitial component within the spinal trigeminal tract just above the caudal 715 
half of Sp5i (Phelan & Falls, 1989), which is heavily innervated by trigeminal afferents, 716 
particularly from its mandibular division  (Jacquin et al., 1983; Jacquin et al., 1988; Marfurt & 717 
Rajchert, 1991; Shigenaga et al., 1986). In Pa5 a multitude of nociceptive and visceroceptive 718 
afferents converge that are involved in the modulation of cardiovascular and nocifensive 719 
responses to widely diverse stimuli: being a target for glossopharyngeal afferents, probably 720 
arising from its jugular ganglion, Pa5 plays a role in the baroreceptor reflex arch (Yu & 721 
Lindsey, 2003), and relays to the diencephalon sensory signals from the upper respiratory 722 
tract (Driessen, Farrell, Mazzone & McGovern, 2015; McGovern et al., 2015). In addition, 723 
Pa5 responds to nociceptive stimuli from other disparate somatic and visceral territories, 724 
including the sciatic and orofacial regions, esophagus and urinary bladder, putatively 725 
mediating not only sensations but also cardiovascular responses that accompany 726 
somatosensory-evoked reflexes  (Alioto, Lindsey, Koepp & Caous, 2008; Arvidsson & 727 
Thomander, 1984; Bon, Lanteri-Minet & Menetrey, 1997; Caous, Koepp, Couture, Balan & 728 
Lindsey, 2008; Imbe & Ren, 1999; McGovern et al., 2015; Suwanprathes, Ngu, Ing, Hunt & 729 
Seow, 2003; Yu & Lindsey, 2003). 730 
4.5.  The GON as a target for therapeutic interventions: the value of a rat model   731 
Clinical phenomena of spread and referral of pain are common in primary painful 732 
craniofacial disorders. Although the pathophysiology of these phenomena is not entirely clear 733 
yet, it is widely accepted that nociceptive input-induced sensitization has to occur in second-734 
order neurons on which primary afferents from separate territories converge (Arendt-Nielsen, 735 
2015; Basbaum, Bautista, Scherrer & Julius, 2009; Woolf, 1991). This mechanism has been 736 
proposed to underlie the origin of pain in neurovascular headaches, in particular migraine and 737 
trigeminal autonomic cephalalgias such as cluster headache (Bartsch & Goadsby, 2003; 738 
Goadsby, 2006; Goadsby et al., 2017; Jacobs & Dussor, 2016). Once the sensitization is 739 
established, sensory stimuli on specific targets (trigger points) would spark pain in the 740 
territories whose innervation converges upon the sensitized neurons. As described above, 741 
some neural regions in the TCC and neighboring structures receive convergent afferents from 742 
the GON and various cutaneous, muscular, dural, and visceral trigeminal sources. Using the 743 
rat as a model Peter Goadsby and his colleagues were the first to demonstrate direct functional 744 
coupling of nociceptive supratentorial dural afferents and cervical afferents conveyed through 745 
the GON on upper cervical DH neurons. These neurons, located in laminae IV-VI and to a 746 
lesser extent in laminae I-II, mainly corresponded to the wide dynamic range type and showed 747 
sensitization in their responses to dural stimulation following GON electrical stimulation 748 
(Bartsch & Goadsby, 2002). Conversely, dural stimulation increased the responses of these 749 
neurons to GON electrical stimulation, and lowered their response thresholds and expanded 750 
their receptive fields upon innocuous mechanical testing in the occipito-cervical region and 751 
the ophthalmic and caudal parts of the maxillary and mandibular territories (Bartsch & 752 
Goadsby, 2003).  753 
These findings gave experimental support to the clinical practice of pharmacologically 754 
blocking the GON, which for many years was used to treat various headaches (reviewed in 755 
Young, 2010), and which has received renewed attention more recently as a proven therapy 756 
for refractory migraine and cluster headache (Cuadrado et al., 2017; Gul, Ozon, Karadas, Koc 757 
& Inan, 2017; Tang et al., 2017). Moreover, after a number of open-label clinical trials 758 
reported beneficial effects of GON subcutaneous stimulation for various painful craniofacial 759 
conditions, a randomized, double-blind and controlled study  (Saper et al., 2010) showed that 760 
GON stimulation provided significant improvement to medically intractable chronic migraine 761 
cases, including some who did not respond to GON block. Unsurprisingly, GON stimulation 762 
has been increasingly used along the last decade to treat refractory migraine and trigeminal 763 
autonomic cephalalgias (Dodick et al., 2015; Lambru et al., 2014; Lambru, Shanahan, 764 
Watkins & Matharu, 2014;  Miller, Watkins & Matharu, 2016; Miller, Watkins & Matharu, 765 
2017; Rodrigo et al., 2017).   766 
The surge in clinical interest in GON neuromodulation propelled a search for the 767 
mechanisms involved, an endeavor in which the use of rat craniofacial pain models is 768 
invaluable. So far, only a few acute and short-term studies are available in rats, that indicate 769 
that GON stimulation induces lasting elevations of mechanical (but not thermal) thresholds in 770 
the forepaw and periorbital region (De La Cruz et al., 2015), and decreases spontaneous 771 
activity and responsivity to receptive field stimulation of neurons in laminae II-IV neurons of 772 
the medullary DH that receive converging input from the supra- and/or infraorbital skin, the 773 
supratentorial dura, and the GON (Lyubashina et al., 2017). A neuromodulatory effect of 774 
GON stimulation has also been reported on thalamic neurons upstream the trigeminal 775 
somatosensory pathways, which become sensitized in a migraine model, but reduce their 776 
spontaneous and facial and forepaw mechanical stimulation-evoked activity during GON 777 
stimulation (Walling et al., 2017).  778 
In sum, the GON in the rat is a relatively easily accessible sensory nerve that may be a 779 
key target for examining a variety of mechanisms of the physiology of craniocervical 780 
nociception, as well as the pathophysiology of severe chronic painful disorders strongly 781 
linked to human clinical conditions. Present findings may be valuable for a better 782 
understanding of the neural bases of sensory convergence on spinomedullary systems, which 783 
could help refine and advance available experimental approaches in this field. 784 
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TABLE 1 1086 
List of antibodies used in this study 1087 
Antibodies Immunogen Manufacturer Dilution 
Anti- Griffonia 
Simplicifolia Lectin I 
Lectin I purified from Griffonia 
(Bandeiraea) Simplicifolia 
Vector Laboratories goat polyclonal, 






Nondenatured CTB isolated 
from Vibria cholerae 
 
Sigma-Aldrich, rabbit polyclonal,  








Denatured TH from rat 
pheochromocytoma 
 
Merk, rabbit polyclonal,  







Human placental enzyme. Merck, goat polyclonal,  







Gamma Immunoglobins Heavy 
and Light chains 
 
ThermoFisher, goat polyclonal,  










ThermoFisher, rabbit polyclonal, 






Anti-Goat IgG  
 
Purified goat IgG 
 
Vector Laboratories, rabbit polyclonal, 





Anti-Rabbit IgG Biotin 
Conjugate 
 
Purified rabbit IgG 
 
 
Sigma Aldrich, goat polyclonal,  





TABLE 2 1090 
Neuron number (N; mean±sd) and cell body volume (V; mean±sem) in the left (L, n=6) and right (R, 1091 
n=8) DRG C2 and C3. †p=0.030 and *p=0.028 (R vs. L; Wilcoxon paired test) 1092 
   N (x10-3)   V (m3x10-3)  
Ganglion Side A B C All A B C All 
C2 L 1.49±0.6 6.16±3.1 3.08±0.9 10.72±4.3 25.58±1.4 7.82±0.3 2.57±0.1 8.99±0.4 
 R 1.25±0.6 4.16±0.8 3.55±1.4 8.97±2.4 31.14±1.8† 7.43±0.2 2.59±0.1 9.00±0.6 
 L+R 2.87±0.7 10.67±3.2 7.30±1.8 20.83±5.4     
C3 L 1.59±0.4 4.44±0.9 3.12±0.9 9.16±2.1 25.09±1.9 7.23±0.3 2.45±0.1 8.94±0.4 
 R 1.35±0.3 4.28±1.2 3.40±1.1 9.03±1.9 27.30±0.8 7.62±0.3 2.61±0.1 9.24±0.6 
 L+R 2.87±0.3 8.40±2.1 6.25±1.6 17.51±3.7     
C2+C3 L 3.04±0.7 10.96±2.8 6.29±1.1 20.29±3.8 24.94±0.6  7.41±0.1 2.55±0.03 8.94±0.1 
 R 2.69±0.7 8.65±1.4 6.91±1.4 18.25±2.6 28.91±0.3* 7.61±0.01 2.54±0.02 8.90±0.2 
 1093 
TABLE 3 1094 
Estimates of morphometric parameters in the rat left (L, 1095 
n=5) and right (R, n=6) GONs: N, number of myelinated 1096 
(MAx) and unmyelinated axons (UAx); g-ratio, the ratio 1097 
between the diameters of the axon and the nerve fiber 1098 
obtained from the area measurements of each myelinated 1099 
fiber; AInt, percentage of the nerve occupied by interstitium 1100 
(including endo- and perineurium, Schwann and other cells; 1101 
excluding epineurium and large blood vessels). AMf, 1102 
percentage of the nerve occupied by myelinated fibers. CV, 1103 
coefficient of variation. 1104 
  L  R  
 Mean sd CV  Mean sd CV 
N(Max) 825 441 0.53  975 173 0.18 
N(UAx) 2913 958 0.33  3688 998 0.27 
g-ratio (%) 47.2 2.4 0.05  47.5 4.0 0.08 
AMf (%) 61.9 4.0 0.06  60.2 5.2 0.09 
AInt (%) 34.2 3.1 0.09  34.9 5.2 0.15 
 1105 
  1106 
Figure 1. Illustration of a dorsal view of occipital and neck regions of the rat, with the 1107 
skin removed to show the superficial muscles and the course of the GON and 3d occipital 1108 
nerve. Only the muscles readily identifiable are depicted. On the left, the superficial fascia is 1109 
removed; on the right the most superficial muscles are also partially removed to show more 1110 
clearly the course of the nerves at deeper levels. Exposed nerves are drawn in solid white; 1111 
their muscle-covered courses are marked as gray traces. 3dON, third occipital nerve; AS, m. 1112 
auricularis superior; AT, m. acromiotrapezius;  CT, m. clavotrapezius; FA, m. frontalis, pars 1113 
auricularis; GON, greater occipital nerve; LAL, m. levator auris longus; SC, m. splenius 1114 
capitis; T, m. temporalis. 1115 
Figure 2. Sketch of the dorsal roots, ganglia and spinal nerves C2 and C3, the 1116 
communicating branches between adjacent spinal nerves and the distribution of the GON and 1117 
3dON. The loaded pipette points to the location of the tracer deposits in the GON before it 1118 
divides into its two main terminal branches. 1119 
Figure 3. Example of a tracer injection in the GON. A: Exposure of the nerve during 1120 
surgery. B: Intraneural injection of a mixture of CTB-IB4, with traces of the supravital dye 1121 
Light Green to facilitate the visualization of the injection; the photo was taken immediately 1122 
after the injection. Scale bar 1 mm. 1123 
Figure 4. Examples of immunofluorescent neurons in sections of the right DRG C2 (A) 1124 
and C3 (B). Magenta, green and blue channels are used to identify CTB-, IB4- and 1125 
Bisbenzimide-labeled cell bodies and nuclei, respectively. Double-labeled neuronal perikarya 1126 
appear in C2 in the merged image (panel on the right; see also Fig. 5). Scale bars 100 µm. 1127 
Histograms show the estimations of the total number (mean+sd) of single- and double-labeled 1128 
neurons in each ganglion.  1129 
Figure 5. High-power view of CTB- (magenta) and/or IB4-labeled (green) neurons in C2. 1130 
While most CTB-labeled neurons are large or medium-sized, some are definitely small (B and 1131 
C, thin arrows). Likewise, most IB4-labeled cells are small-to-medium sized, but a few 1132 
examples occur of strongly labeled fairly large neurons (A, thick arrow). Most double labeled 1133 
neurons belong within the small or medium-size range (C, arrowheads). Scale bar 50 µm. 1134 
Figure 6. Low-power confocal images of C2 (A) and C3 (B) ganglia sections displaying 1135 
maximum retrograde labeling after a FB deposit in GON. Scale bar 200 µm. The inset shows 1136 
the stereological estimate of total number (mean+sd) of FB-labeled neurons in these ganglia. 1137 
Figure 7.  A: Low-power view of IB4-immunofluorescent terminal field in lamina II 1138 
under confocal microscopy on a horizontal section of the upper cervical spinal cord. Arrows 1139 
point to needle holes that were made midway between the insertion on the spinal cord of 1140 
dorsal roots C2-C3 and C3-C4 before extracting the tissue after perfusion to serve as fiducial 1141 
marks. B: Higher-power detail of the nearly complementary laminar terminal pattern of CTB- 1142 
(magenta) and IB4-immunofluorescent (green) central projections of the GON in the DH of 1143 
the spinal cord. While IB4-labeled fibers and varicosities are largely restricted to the outer 1144 
two-thirds of lamina II, CTB-labeled profiles are present in lamina I and lamina III-IV, and 1145 
also appears in the deeper part of lamina II, intermingling to some extent with IB4 labeling. 1146 
Where there is topographical overlap, also a fraction of the terminals show co-localization of 1147 
both tracers (not shown). Short vertical lines (top right corner) mark laminar boundaries, from 1148 
the pial surface (right) to laminae II-III border (left). Scale bars 500 µm (A) and 100 µm (B). 1149 
Figure 8. Distribution of CTB-immunolabeled afferent projections from the GON in the 1150 
cervical spinal cord and caudal brainstem. A: Series of eight DAB-reacted horizontal sections 1151 
arranged dorso-ventrally (‘a’ through ‘h’, from left to right), with a 240 µm separation 1152 
between adjacent sections. Sections are aligned rostro-caudally to preserve relative locations 1153 
of labeling at different depths. Arrowhead in section ‘a’ marks the approximate location of the 1154 
obex, and thick arrows in section ‘d’ point to the center of C2 and C3 dorsal roots, as indicated 1155 
by the nearby reference needle holes (see Fig. 7). Contrast and brightness were adjusted to 1156 
enhance visualization. B: Close up pictures of the labeled territories numbered in A (long 1157 
arrows): 1 and 6, uneven projections at dorsal and ventral parts of the outermost region of 1158 
Sp5i; 2 and 3, dense labeling in laminae III and IV of the DH, that extends from segmental 1159 
level C1, where spinal and medullary DH merge, to segment C6; 4, separate patches of dense 1160 
terminal fields that rostrally directed GON afferents leave medially in upper cervical and 1161 
medullary DH; 5, in contrast, caudal divisions of GON afferents entering through C2 dorsal 1162 
root (top) leave a few small and discrete dense terminal patches more laterally in the DH. 1163 
Short arrows  in A indicate the dense bundle of labeled fibers placed at more dorsal and 1164 
rostral levels (‘a’), strongly labeled C2 rootlets (‘b’), and a few labeled fibers in the solitary 1165 
complex crossing to the contralateral side (‘d’). Sp5c, caudal  trigeminal nucleus; Sp5i, 1166 
interpolar trigeminal nucleus; Cu, cuneate nucleus; DC, dorsal column; Gr, gracile nucleus; 1167 
LC, lateral column. Scale bars 1 mm (A) and 50 m (B). 1168 
Figure 9: Distribution of CTB- (magenta) and IB4-labeled (blue) GON afferents in 1169 
spinal cord and brainstem territories in one case cut on the coronal plane. Labeled fibers and 1170 
boutons in selected sections at the indicated levels were digitally enhanced and superimposed 1171 
on attenuated greyscale images of adjacent Nissl-stained sections. Relevant nuclear or laminar 1172 
boundaries are outlined. Anatomical terms follow Paxinos & Watson (1986) and Bermejo et 1173 
al (2003): Bi, nucleus Bischoff; C1-4, spinal segmental levels; CuE, external cuneate nucleus; 1174 
CuM, cuneate nucleus, medial division; CuR, cuneate nucleus, rostral division; Gr, gracile 1175 
nucleus; NBi, internal basilar nucleus; Pa5, paratrigeminal nucleus; Sol, solitary nucleus; 1176 
Sp5cc, caudal trigeminal nucleus (caudal level); Sp5cr, caudal  trigeminal nucleus (rostral 1177 
level); Sp5i, interpolar trigeminal nucleus; x, nucleus x; z, nucleus z; I-V, dorsal horn or Sp5c 1178 
laminae; XII, hypoglossal nucleus. Scale bar 500 µm.   1179 
Figure 10:  Examples of different types of CTB-labeled axons and varicosities in six 1180 
central territories innervated from the GON. A:  Large and medium-sized varicosities 1181 
predominate in the terminal patches in medial lamina III of the spinal DH (Fig. 8c). B: In 1182 
contrast, small- and medium-sized varicosities dominate in the rostral Cu (Fig. 8a). C: Small, 1183 
mainly en passant varicosities with scattered very large ones appear in the paratrigeminal 1184 
nucleus. D: Isolated varicose axons that aggregate in occasional islands in lamina V of the 1185 
spinal cord. E: Dense terminal field with heterogeneous varicosities of a wide range of sizes 1186 
in lamina III of the spinal DH (Fig. 8d). F: Long axons thickly populated by en passant 1187 
varicosities, most of them small, in lamina I of the spinal cord (Fig. 8d). Not uncommonly, 1188 
varicosities accumulate in dense shapes that appear to delineate the typical flattened and 1189 
elongated profiles of neurons in this lamina (arrowhead). Scale bar 10 m. 1190 
Figure 11: Volume of central structures innervated by GON primary afferents in millions 1191 
of cubic micra (mean+sem). In “Sp5i” it is included the territory of innervation in the 1192 
paratrigeminal nucleus. “DCN” includes terminals in the rostral and external cuneate nuclei 1193 
and less well defined adjacent cell groups, such as nucleus x or the dorsolateral reticular 1194 
nucleus. And “DH-deep” refers to all labeled fibers and varicosities in or deeper to inner part 1195 
of lamina IV.  1196 
Figure 12: A: Distribution of perikaryal volumes of all neuron types in ganglia C2 and C3 1197 
pooled, plotted as frequencies over a log-transformed size scale (n = 10 rats). No statistical 1198 
differences exist between right and left sides. B: Differences in cell body size exist, however, 1199 
between the large, A-type cells in the left and right ganglia. As shown in the inset, the volume 1200 
of A-type cells is significantly higher on the right side with respect to the left (p=0.028, 1201 
Wilcoxon signed-rank test).  1202 
Figure 13: A: Toluidine-stained semithin cross-sections of the GON in three cases that 1203 
illustrate the variety of sizes and fascicle composition of this nerve at the level of the tracer 1204 
injection. The extensive epineurium has been trimmed on the edges for better visualization of 1205 
the fascicles. B: Typical ultrastructure of the GON, showing large and small myelinated 1206 
fibers, and two Remak bundles (asterisks) with 7 and 13 unmyelinated axons, respectively. 1207 
Scale bars 100 µm (A) and 1 µm (B). 1208 
Figure 14: As an index of myelination, the g-ratio correlates highly significantly with the 1209 
size of the myelinated axons (MAx) in the GON, fitting an exponential regression, with the 1210 
finely MAx tending to have lower values of g-ratio. Values represent mean±sem for each 1211 
axon cross-sectional size (on a log scale). 1212 
Figure 15: Two examples of electron micrographs of selected spots in transverse ultrathin 1213 
sections of the GON (A, B) followed by adjacent corresponding semithin sections 1214 
immunoreacted for TH or ChAT. Arrows point to small groups of TH-positive inmunolabeled 1215 
UAx. Not a single MAx profile displayed ChAT inmunolabeling. Scale bar 2 μm. 1216 
